ALLMedicine™ Angioimmunoblastic T-cell Lymphoma Center
Research & Reviews 557 results
https://doi.org/10.1002/dc.24726
Diagnostic Cytopathology; van den Akker TA, Chen H
Feb 25th, 2021 - Fine needle aspiration (FNA) is a minimally invasive technique used in the initial diagnosis of superficial lesions, including lymphadenopathy. Its benefit in lymph node pathology, however, is highly variable, especially in heterogeneous lymphopro...
https://doi.org/10.1093/ajcp/aqaa249
American Journal of Clinical Pathology; Abukhiran I, Syrbu SI et. al.
Feb 24th, 2021 - Follicular helper T cell (TFH) markers are expressed in angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma of the TFH phenotype (PTCL-TFH). However, differential expression and coexpression of these markers in benign and othe...
https://doi.org/10.3324/haematol.2020.265991
Haematologica Dobson R, Du PY et. al.
Feb 11th, 2021 - Angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma with T follicular helper phenotype (PTCL-TFH) are a group of complex clinicopathological entities that originate from TFH cells and share a similar mutation profile. Their di...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839364
Blood Advances; Lemonnier F, Safar V et. al.
Jan 26th, 2021 - Angioimmunoblastic T-cell lymphoma (AITL) is a frequent T-cell lymphoma in the elderly population that has a poor prognosis when treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) therapy. Lenalidomide, which has been ...
https://doi.org/10.1097/RLU.0000000000003486
Clinical Nuclear Medicine; Fernández-Rodríguez P, Tamayo Carabaño D et. al.
Jan 14th, 2021 - A 50-year-old man with angioimmunoblastic T-cell lymphoma in complete response to treatment presented new hypermetabolic brain lesions on 18F-FDG PET/CT suggestive of malignancy. These findings were correlated by MRI that showed cortical-subcortic...
Clinicaltrials.gov 571 results
https://doi.org/10.1002/dc.24726
Diagnostic Cytopathology; van den Akker TA, Chen H
Feb 25th, 2021 - Fine needle aspiration (FNA) is a minimally invasive technique used in the initial diagnosis of superficial lesions, including lymphadenopathy. Its benefit in lymph node pathology, however, is highly variable, especially in heterogeneous lymphopro...
https://doi.org/10.1093/ajcp/aqaa249
American Journal of Clinical Pathology; Abukhiran I, Syrbu SI et. al.
Feb 24th, 2021 - Follicular helper T cell (TFH) markers are expressed in angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma of the TFH phenotype (PTCL-TFH). However, differential expression and coexpression of these markers in benign and othe...
https://doi.org/10.3324/haematol.2020.265991
Haematologica Dobson R, Du PY et. al.
Feb 11th, 2021 - Angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma with T follicular helper phenotype (PTCL-TFH) are a group of complex clinicopathological entities that originate from TFH cells and share a similar mutation profile. Their di...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839364
Blood Advances; Lemonnier F, Safar V et. al.
Jan 26th, 2021 - Angioimmunoblastic T-cell lymphoma (AITL) is a frequent T-cell lymphoma in the elderly population that has a poor prognosis when treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) therapy. Lenalidomide, which has been ...
https://doi.org/10.1097/RLU.0000000000003486
Clinical Nuclear Medicine; Fernández-Rodríguez P, Tamayo Carabaño D et. al.
Jan 14th, 2021 - A 50-year-old man with angioimmunoblastic T-cell lymphoma in complete response to treatment presented new hypermetabolic brain lesions on 18F-FDG PET/CT suggestive of malignancy. These findings were correlated by MRI that showed cortical-subcortic...
News 19 results
https://www.mdedge.com/fedprac/avaho/article/207820/lymphoma-plasma-cell-disorders/angioimmunoblastic-t-cell-lymphoma?channel=53
Ermann DA, Vardell VA et. al.
Sep 9th, 2019 - Background: Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive malignancy, representing approximately 18. 5% of Peripheral T-cell lymphomas.
https://www.mdedge.com/hematology-oncology/article/206189/t-cell-lymphomas/hdac/hma-combo-shows-remarkable-activity-ptcl?channel=303
Neil Osterweil
Aug 9th, 2019 - LUGANO, SWITZERLAND – A combination of 5-azacytidine and romidepsin showed promising activity in patients with peripheral T cell lymphomas, particularly angioimmunoblastic T-cell lymphoma (AITL) and primary cutaneous follicular helper T-cell lymph.
https://www.mdedge.com/hematology-oncology/article/193975/lymphoma-plasma-cell-disorders/cerdulatinib-yields-encouraging?channel=39313
Jennifer Smith
Feb 6th, 2019 - LA JOLLA, CALIF. – The spleen tyrosine kinase/Janus kinase inhibitor cerdulatinib has demonstrated activity against relapsed and refractory T-cell lymphomas.
https://www.mdedge.com/hematology-oncology/article/193912/lymphoma-plasma-cell-disorders/combo-emerges-bridge-transplant/page/0/1?channel=39313
Feb 5th, 2019 - Efficacy with romidepsin Among all evaluable PTCL patients in the romidepsin arm, the ORR was 59% (16/27), and the CR rate was 33% (9/27). Responses occurred in seven patients with PTCL not otherwise specified (NOS), six with angioimmunoblastic T-.
https://www.mdedge.com/hematology-oncology/article/193002/t-cell-lymphomas/four-drug-combo-shows-durable-responses-relapsed
Jennifer Smith
Jan 19th, 2019 - LA JOLLA, CALIF. — Results of a phase 1 trial suggest a four-drug combination can produce durable responses in patients with relapsed or refractory T- and B-cell lymphomas.